Immuno Oncology Drugs Market Opportunities, Business Forecast To 2030
The report "Immuno Oncology Drugs Market by Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others), by Application (Breast Cancer, Blood cancer, Liver Cancer, Brain cancer, Colorectal Cancer, Others), by End Users (Hospitals, Ambulatory Centers, Clinics, Academic Institutes)) - Global Forecasts to 2030" The global Immuno Oncology Drugs Market is projected to reach USD 56.28 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 10% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=36784 Competitive Dashboard: The prominent key players operating in the global Immuno Oncology Drugs Market are Merck & Co. Inc. (U.S.) Hoffmann-La Roche AG (Switzerland) Spectrum Pharmaceuticals U.S.) Eli Lilly and Company (U.S.) Amgen Inc. (U.S.) Bristol-Meyer Squibb (U.S.) Sanofi S.A. (France) AstraZeneca plc (U.S.) 3M Company (US)...